GeneDx Hldgs (NASDAQ:WGS) reported quarterly earnings results on February 23, 2026 that exceeded analyst expectations.
The Healthcare company reported earnings per share of $0.14, beating the consensus estimate of $0.12 by $0.02 per share. Revenue came in at $121.0M, beating the estimate of $119.9M.
GeneDx Hldgs's stock moved following the earnings release. The stock currently trades at $81.71 with a market capitalization of $4.5B.